Bard PowerPort Lawsuit 2026: 5 Documents That Decide What Your Claim Is Worth

A Bard PowerPort claim rises or falls on five records: the implant operative report, imaging showing fracture or migration, the complication and re-intervention record, hospital device-identification records, and documented bills and lost income. In MDL 3081 — 4,140 cases pending October 1, 2026 — bellwether juries have split between a defense verdict and a $40 million award.

  • Federal PowerPort lawsuits are centralized as MDL 3081 in the U.S. District Court for the District of Arizona before Judge David G. Campbell, coordinated since August 2023.
  • As of October 1, 2026, the MDL held 4,140 pending actions — an increase of 406 cases in a single month.
  • The first bellwether trial (Cook) ended May 8, 2026, with a defense verdict: the jury found Bard not negligent on failure-to-warn claims and deadlocked on the design-defect claim.
  • The second bellwether (Divelbliss v. Becton Dickinson) produced a $40 million verdict on September 4, 2026 — the MDL's first plaintiff win — for a fractured catheter that caused serious cardiac complications.
  • The third bellwether (Lattanzio, an infection and sepsis case) began trial October 13, 2026, after the judge denied Bard's summary-judgment motion on September 25; further trials are scheduled for December 2026 and February 2027.

For a plain-language walkthrough of how bellwether trials shape a mass tort, the Problem Solved channel explains the process step by step.

Why two juries saw the same device and reached opposite results

A bellwether trial is a test case chosen from thousands of similar lawsuits so both sides can see how juries respond to the evidence. The Cook jury heard a failure-to-warn case and sided with Bard on negligence, while hanging on the design-defect question. The Divelbliss jury heard a catheter-fracture case backed by imaging and records showing the catheter had fractured and caused serious heart complications — and awarded $40 million. The difference was the documents, not the rhetoric. That is why firms build every PowerPort file around the same five records; the full trial calendar and case count are tracked in our October 2026 litigation update.

Document 1: the implant operative report

The operative report is the surgeon's account of the day the port went in: the device model implanted, the insertion site, the technique, and any complications. It anchors the entire timeline — proving which device you received and when. Hospitals retain these records for years, and your attorney can request them with a signed medical authorization. If the port was placed during chemotherapy, oncology or infusion records from the same period corroborate the date.

Document 2: imaging that shows fracture or migration

In a catheter-fracture claim, nothing persuades like an image. CT scans, chest X-rays, and fluoroscopy studies visibly showing a fractured, kinked, or migrated catheter fragment — sometimes lodged in the heart or a major vessel — are the evidentiary centerpiece of the strongest cases. The $40 million Divelbliss verdict rested on precisely this proof. Gather every scan taken after symptoms began, not only the most recent: progression across images tells its own story. Our companion guide explains which catheter fractures and migrations typically qualify for a claim.

Document 3: the complication and re-intervention record

Beyond fracture, the litigation covers infections and sepsis, deep vein thrombosis (DVT) — a clot forming in a deep vein, often near the catheter — embolism, perforation of vessels or organs, and fluid buildup around the heart. The third bellwether trial centers on a bloodstream infection and sepsis allegedly caused by the port. Emergency-room records, blood-culture results, infectious-disease consults, and the operative report from the removal or revision surgery prove the complication was real, serious, and tied to the device. Keep every discharge summary and follow-up note.

Document 4: the device-identification record

Hospitals log the specific model and lot number of every implanted device. This connects your injury to the Bard PowerPort and related Bard port catheters at the heart of the litigation, rather than to a generic implanted port. In multidistrict litigation, where thousands of plaintiffs allege the same design problem, model and lot identification places your case inside the consolidated proceedings. Request the "implant log" or "device sticker" page from the hospital's medical-records department. It also matters because your port was never subject to a general recall — yet claims still proceed.

Document 5: the cost record — bills, lost income, and caregiving

Compensation is built from documented losses: hospital and surgical bills, emergency visits, medications, travel for treatment, wages lost during recovery, and family caregiving. Organize everything chronologically — even small receipts. Most product-liability attorneys evaluate these cases on contingency, meaning no upfront fee and a percentage only if the case results in compensation; firms ask for this file early to assess the case's real economic weight.

What weakens a claim: the three gaps attorneys flag most

Firms report the same three weaknesses repeatedly. First, a missing implant record — without proof of which device was implanted, the case cannot enter the MDL's framework. Second, symptoms with no timely imaging or treatment record; a fracture discovered years later, with no documented complaints between, invites the defense to blame intervening causes. Third, long unexplained delays before legal action, which collide with state filing deadlines — typically around two years in many states, with complicated questions about when the clock started. None is automatically fatal, but each costs leverage.

Who Benefits From This — and Who Does Not

A PowerPort claim rewards documented device failure, not worry about the device. The files that win are the files with the five records.

Who benefits:

  • Patients whose imaging shows a fractured, kinked or migrated catheter fragment: The $40 million Divelbliss verdict rested on imaging plus records showing fracture and serious heart complications.
  • Patients with documented device complications: Infections and sepsis, deep vein thrombosis, embolism, perforation or fluid buildup around the heart, backed by emergency records, blood cultures and removal or revision surgery reports.
  • Patients who assemble the five records: The implant operative report, imaging, the complication and re-intervention record, hospital device-identification records, and documented bills and lost income.

Who benefits little or not at all:

  • Patients without an implant or device-identification record: Without proof of which device was implanted, the case cannot enter the MDL framework.
  • Patients with symptoms but no timely imaging or treatment record: A fracture discovered years later with no documented complaints between invites the defense to blame intervening causes.
  • People expecting a settlement payout now: No global settlement has been announced as of October 2026, and the split bellwether results, one defense verdict and one $40 million award, show individual outcomes vary.

Related reading: Bard PowerPort Lawsuit 2026: $40 Million Verdict, Bellwether Trials, and Who Can File.

Frequently asked questions

Is there a Bard PowerPort settlement yet?

No global settlement has been announced as of October 2026. Cases are proceeding individually through the federal MDL, where two bellwether verdicts have split — one defense win, one $40 million plaintiff award — with three more trials scheduled through February 2027.

How much is a Bard PowerPort claim worth?

Compensation varies widely by case, and most settlements are confidential, so no honest average exists. The only public figures are the two bellwether outcomes: a defense verdict in May 2026 and a $40 million verdict in September 2026 for a fractured catheter that caused serious cardiac complications.

What injuries are linked to the Bard PowerPort?

The lawsuits allege catheter fracture and migration, infections and sepsis, deep vein thrombosis and embolism, perforation of tissues, vessels, or organs, irregular heartbeat, fluid buildup on the heart, severe persistent pain, and wrongful death.

Was the Bard PowerPort recalled?

There has been no general recall of the PowerPort, though some models have drawn FDA attention over labeling and device issues. Claims proceed regardless, because a recall is not a legal prerequisite for a product-liability lawsuit.

Can I still file a PowerPort lawsuit in 2026?

Yes. The federal MDL remains open with more than 4,100 pending cases, and attorneys are still accepting new claims for catheter fractures, migration, infections, blood clots, and other serious complications. State filing deadlines apply, so a prompt legal evaluation matters.

Who benefits from a Bard PowerPort claim — and who does not?

Patients benefit most when imaging shows a fractured or migrated catheter and complication records document infections, sepsis, clots, embolism or perforation, with the full five-record file behind the claim. Patients without an implant or device-identification record cannot place their case inside the MDL framework, and people expecting a settlement payout now will be disappointed, since no global settlement has been announced as of October 2026.

This article provides general information only — not legal advice. Lawsuit deadlines and qualification rules vary by state; consult a licensed attorney about your situation.

Watch on YouTube

Problem Solved on YouTube